Navigation Links
Desert rhubarb -- a self-irrigating plant
Date:7/1/2009

Researchers from the Department of Science Education-Biology at the University of Haifa-Oranim have managed to make out the "self-irrigating" mechanism of the desert rhubarb, which enables it to harvest 16 times the amount of water than otherwise expected for a plant in this region based on the quantities of rain in the desert. This is the first example of a self-irrigating plant worldwide.

The desert rhubarb grows in the mountains of Israel's Negev desert, where average precipitation is particularly low (75 mm per year). Unlike most of the other desert plant species, which have small leaves so as to minimize moisture loss, this plant is unique in that its leaves are particularly large; each plant's rosette of one to four leaves reaches a total diameter of up to one meter. Prof. Simcha Lev-Yadun, Prof. Gidi Ne'eman and Prof. Gadi Katzir came across this unique plant growing in the desert while studying the field area with students of the Department of Science Education-Biology of the University of Haifa-Oranim, and noticed that its leaves are unusually large and covered with a waxy cuticle. They observed an exceptionally ridged structure on each leaf, forming a leaf structure that resembles the habitat's mountainous topography.

The scientists explained that these deep and wide depressions in the leaves create a "channeling" mountain-like system by which the rain water is channeled toward the ground surrounding the plant's deep root. Other desert plants simply suffice with the rain water that penetrates the ground in its immediate surroundings.

The findings have shown that the natural selection process has resulted in the evolution of this plant's extremely large leaves, which improved its ability to survive in the arid climate of the desert. The results of experiments and analysis of the plant's growth - in an area with an average annual rainfall of 75 mm - showed that the desert rhubarb is able to harvest quantities of water that
'/>"/>

Contact: Rachel Feldman
rfeldman@univ.haifa.ac.il
972-482-88722
University of Haifa
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Sands of Gobi Desert yield new species of nut-cracking dinosaur
2. World Day to Combat Desertification focuses on human security
3. A research work will be the reference to characterize the climatic impact of desert dust
4. Desert woodrats switch one dietary poison for another
5. Desert woodrats switch one dietary poison for another
6. Geology and biology meet in the history of US southwestern desert surface waters
7. Small desert beetle found to engineer ecosystems
8. Tiny dust particles from Asian deserts common over western United States
9. UNCCD recognizes importance of satellites for combating desertification
10. Can a new implant coating technique create a new six million dollar man?
11. Ovarian transplantation: First baby is born after a new technique

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Desert rhubarb -- a self-irrigating plant
Desert rhubarb -- a self-irrigating plant
(Date:11/4/2009)... 20 Quest Diagnostics In...ider of diagnostic testing, information and servic...tember 30, 2009, income from continuing operations... from $160 million, or $0.81 per diluted share, fo...r results were reduced by a $0.03 per share charge...
(Date:11/4/2009).... 20 Aware, Inc. (Nasdaq...ogy and biometrics software, today reported financ... 30, 2009. ,, Michael Tzannes, Aware,s Chairm...ay, we announced an agreement to sell our DSL and ...less semiconductor company being spun out of Infin...
(Date:11/4/2009)...ct. 23 GenVault Corporation, the l...for genomic discovery, medicine and identification...lt,s President and CEO, will be presenting at the ... 26th and 27th in La Jolla, CA. ,, During the p...f the company together with recent customer, techn...
Breaking Biology News(10 mins):Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 1Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 2Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 3Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 4GENova gains access to Big Pharma 57148 1GENova gains access to Big Pharma 57148 2GENova gains access to Big Pharma 57148 3Frost 26 Sullivan 3A First Responders Communication Interoperability A Vital Need for Life Saving Services 57146 1Frost 26 Sullivan 3A First Responders Communication Interoperability A Vital Need for Life Saving Services 57146 2
...f the words "parasitic worms," it,s a fact that so...At Michigan State University, researcher Linda Man...vestigating the role that parasites can play in tr...ns. , Her research is part of a more than $10 mil...g the Food and Waterborne Diseases Integrated Rese...
...enomes (IMG) data management system of the U.S. De...) has been released to the public. IMG 1.5 now con...chaeal, 15 eukaryotic genomes and 259 bacterial ph...genomes. , IMG 1.5 contains 62 finished and 100 ...total to 162 microbial genomes generated in-house....
...eloped a new low-cost system that analyzes scatter...plications in medicine, food processing and homela...technologies. , The technique - Bacteria Rapid De...s by shining a laser through a petri dish containi.... , "Unlike conventional methods, we don,t have ...
Other Biology News:Parasitic worms used to fight bowel disease 2DOE JGI releases IMG 1.5 with curated archaeal genomes 2Purdue creates new low-cost system to detect bacteria 2Purdue creates new low-cost system to detect bacteria 3Purdue creates new low-cost system to detect bacteria 4
(Date:11/6/2009)...Nov. 6 ,, 3Q09 Cor...Qutenza(TM) E.U. Marketing Authorization to Astell...in commercial readiness activities Expanded manag...arketing; and Director, Commercial Operations App...d Audit Committee chairman , Upcoming 2009 ...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Personalize...o take place on February 22-24, 2010 in Philadelph...ce we will highlight key issues in forming partner...experiences. , Minneapoli...rrowhead’s 2010 Personalized Medicine Partn...
(Date:11/5/2009)...ov. 5 DSM Pharmaceutical Products ...lliance with Galenix, Saint Jean D,Illac, France, ...anufacturing partner for Galenix commercial produc...ollaborate on business development opportunities c...sed on the strength of Galenix in drug product dev...
(Date:11/5/2009)... Transgenomic, Inc. (OTC...esults for the quarter ended September 30, 2009. T...e tables that follow. ,, Third Quarter 2009 ,...r $0.01 per share for the third quarter of 2009 as...hare for the third quarter of 2008. ,, Net sal...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...on (Nasdaq: DNDN ) announced today the closing o...ring of 10,700,000 shares of its common stock, whi...19.20 per share. On May 8, 2009, Deutsche Bank Se...ing, exercised in full its over-allotment option t...n stock at the public offering price of $19.20 per...
...A has approved an,Investigational New Drug (IND) a... phase I clinical study with its selective PLK-1 s...r. PLK-1 is a mitotic kinase required for,the prol...ally bioavailable,highly efficient and well tolera... dosing. This unique inhibitor adds another promis...
...nc. (Xennex) announced today a major leap for Gene...ilable at http://www.genecards.org/v3 . , , ...ntly upgraded infrastructure, including a comprehe... sophisticated and speedier search engine. It prov...rgeted queries, a user-friendly display and clear ...
Other Biology Technology:Dendreon Announces Closing of Common Stock Offering 2Dendreon Announces Closing of Common Stock Offering 3Nerviano Medical Sciences Receives Approval From the FDA to Enter Phase I Clinical Trials for Their Polo Like Kinase (PLK) Inhibitor 2GeneCards(R) Version 3.0 Beta Released 2GeneCards(R) Version 3.0 Beta Released 3
Mouse Anti-Rat KAPPA / LAMBDA Monoclonal Antibody, Horseradish Peroxidase Conjugated, Clone MARK-1 / MARL-15 from Cell Sciences
Human / Mouse / Rat Chk1 Kinase, active ELISA development Kit, DuoSet, IC (Intracellular) from R&D Systems
Bovine Bovine Serum Albumin, Alexa Fluor 680 conjugated/tagged from Molecular Probes (Invitrogen)
Axl, phospho ELISA development Kit, DuoSet IC Economy Pack from R&D Systems
Biology Products: